超声定量血管炎症对巨细胞动脉炎复发的预后价值:MAGiCUS研究
MAGiCUS为国际多中心前瞻性观察研究,纳入156例新诊断巨细胞动脉炎(GCA)患者,在基线及1、3、6、12个月行颞动脉和腋动脉超声,用OGUS评分定量血管炎症。31例(19.9%)复发,基线、1个月和3个月OGUS较高与临床复发风险增加相关。
要点
- 基线OGUS每增加0.1单位,复发风险增加(OR 1.19)。
- 1个月和3个月OGUS每增加0.1单位亦与复发相关(OR 1.37、1.51)。
- 基线、1个月、3个月OGUS预测复发的AUC分别为0.70、0.74、0.67。
核心结论
- 基于超声的血管炎症定量对GCA随访期间复发具有预后价值。
- 基线、1个月和3个月较高的OGUS与临床复发概率增加相关。
研究设计与样本
- MAGiCUS为国际、多中心、前瞻性、观察性研究,纳入新诊断GCA患者。
- 共纳入来自19个中心的156例GCA患者,在基线、1、3、6和12个月行颞动脉和腋动脉超声。
- 血管炎症采用OMERACT GCA超声评分(OGUS)定量。
- 主要结局为6至12个月间首次临床复发。
主要发现
- 156例患者中31例(19.9%)发生复发。
- 未复发患者随访各次OGUS较基线显著降低(-0.15至-0.35)。
- 复发患者基线OGUS显著更高(1.58 vs 1.16,P < 0.001)。
- 多因素分析中,基线OGUS每增加0.1单位与复发相关(OR 1.19;95% CI:1.08,1.34)。
- 1个月OGUS每增加0.1单位(OR 1.37;95% CI:1.17,1.66)和3个月OGUS每增加0.1单位(OR 1.51;95% CI:1.20,1.98)与复发关联仍显著。
关键数值与推荐
- 基线OGUS预测复发的AUC为0.70(95% CI:0.58,0.80)。
- 1个月OGUS预测复发的AUC为0.74(95% CI:0.60,0.85)。
- 3个月OGUS预测复发的AUC为0.67(95% CI:0.56,0.78)。
临床怎么用
- 对新诊断GCA患者,可在基线及随访1、3个月行颞动脉和腋动脉超声并计算OGUS以辅助评估复发风险。
- OGUS较高提示复发概率增加,可考虑加强临床与超声随访监测。
局限性
- 原文摘要未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the prognostic value of ultrasound-based quantification of vascular inflammation for predicting relapses in giant cell arteritis (GCA). METHODS: The Monitoring Activity of GCA through UltraSound (MAGiCUS) project is an international, multicentre, prospective, observational study including newly diagnosed GCA patients. Ultrasound of temporal and axillary arteries was conducted at baseline, 1, 3, 6 and 12 months. Vascular inflammation was quantified using the OMERACT GCA Ultrasonographic Score (OGUS). The primary outcome was the occurrence of the first clinical relapse between 6 and 12 months. RESULTS: Among 156 GCA patients from 19 centres, 31 (19.9%) experienced a relapse. In patients without a relapse, OGUS was significantly lower at all follow-up visits than baseline (-0.15 to -0.35). Baseline OGUS was significantly higher in relapsing patients (1.58 vs 1.16, P < 0.001). In multivariate analysis, an increase in 0.1 units in baseline OGUS was associated with relapse (odds ratio [OR] 1.19; 95% CI: 1.08, 1.34). This association remained significant for 0.1 increases in OGUS at 1 month (OR 1.37; 95% CI: 1.17, 1.66) and at 3 months (OR 1.51; 95% CI: 1.20, 1.98). The areas under the receiver operating characteristic curve for predicting relapse were 0.70 (95% CI: 0.58, 0.80) for baseline OGUS, 0.74 (95% CI: 0.60, 0.85) at 1 month, and 0.67 (95% CI: 0.56, 0.78) at 3 months. CONCLUSION: Ultrasound-based quantification of vascular inflammation has prognostic value for predicting relapses during follow-up in GCA. Higher baseline, 1-month and 3-months OGUS are associated with an increased probability of clinical relapse.
引用
- Molina-Collada J, Cowley S, Kirby C, et al. Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS study. Rheumatology (Oxford). 2026. PMID: 42378435. doi:10.1093/rheumatology/keag341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。